Xingeyuan Biotechnology
PrivateLast Round
Series B
Nov 8, 2021
Total Funding Raised
$170M
Company Overview
Singleron Biotechnologies is a biotechnology company that specializes in single-cell multi-omics analysis technologies, providing molecular diagnostic products and automated equipment for clinical diagnosis, health management, and drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xingeyuan Biotechnology Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Xingeyuan Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 8, 2021 | ||||
| Series A Extension | Dec 29, 2020 | ||||
| Series A Extension | Nov 9, 2020 | ||||
| Series A | Sep 6, 2020 | ||||
| VC Round | Jun 20, 2019 | ||||
Seed | May 1, 2018 |
Xingeyuan Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDH Investments | Series A Extension, Series A, Series B |
| Lake Bleu Capital | Series B |
| Firstred Capital | Series B |
| MSA Capital | Series B |
| ARCH Venture Partners | Series A, Series B |
| Frees Fund | VC Round, Seed |
| ARCH Venture Partners | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2020
$10M raised from CDG Capital, CDH Investments, Lilly Asia Ventures, and SB China Capital.
- Sep 10, 2020
$30M round led by Lilly Asia Ventures
Xingeyuan Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xingeyuan Biotechnology's valuation, stock price, and market status.